Eleutherococcus senticosus 'Siberian Ginseng'

Eleutherococcus senticosus, commonly called Siberian Ginseng, contains eleutherosides—particularly eleutheroside B (syringin) and eleutheroside E—that modulate the hypothalamic-pituitary-adrenal (HPA) axis to support stress resilience and adaptogenic function. Its water-soluble polysaccharides and isofraxidin further contribute to immune stimulation and anti-inflammatory activity via NF-κB pathway inhibition.

Category: Adaptogen Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
Eleutherococcus senticosus 'Siberian Ginseng' — Hermetica Encyclopedia

Origin & History

Eleutherococcus senticosus is a woody shrub native to northeastern Asia, belonging to the Araliaceae family, with the root serving as the primary medicinal part. The extract is derived from the cylindrical, dark brown roots up to 0.5 centimeters in diameter, and is classified as an adaptogenic herbal preparation containing eleutherosides (glycosides), lignans, triterpenoid saponins, coumarins, and essential oils.

Historical & Cultural Context

The research provides limited historical context, noting only modern commercial use as a dietary supplement and cosmetic under the name 'Siberian ginseng.' No detailed traditional medicine system documentation or historical applications were found in the provided sources.

Health Benefits

• Immune system support through water-soluble polysaccharides that demonstrate immune-stimulatory activities via granulocyte and carbon clearance mechanisms (animal studies only)
• Potential anti-inflammatory effects via isofraxidin's inhibition of cyclooxygenase expression and NF-κB pathways (mechanism studies only)
• Mast cell stabilization through ciwujianosides, reducing histamine release triggered by immunoglobulins (in vitro evidence)
• Possible hormonal modulation through binding to estrogen, progestin, mineralocorticoid, and glucocorticoid receptors (in vitro evidence only)
• Antioxidant activity from sesamin and other lignans (compound analysis only, no clinical trials)

How It Works

Eleutheroside B (syringin) and eleutheroside E modulate the HPA axis by influencing cortisol secretion and adrenal gland activity, helping buffer physiological stress responses. Isofraxidin, a coumarin compound, suppresses cyclooxygenase-2 (COX-2) expression and inhibits nuclear factor kappa B (NF-κB) transcriptional activation, reducing pro-inflammatory cytokine production. Additionally, high-molecular-weight polysaccharides activate granulocytes and enhance reticuloendothelial carbon clearance, providing a mechanistic basis for immune-stimulatory effects observed in preclinical models.

Scientific Research

The research dossier contains no human clinical trials, randomized controlled trials, or meta-analyses with PubMed PMIDs. Evidence is limited to animal studies showing polysaccharide fractions suppressing tuberculosis and inhibiting tumor growth in mice, and in vitro studies demonstrating receptor binding activities.

Clinical Summary

Human clinical evidence for Eleutherococcus senticosus is limited but includes several small randomized controlled trials. A notable study (n=45) found that 800 mg/day of standardized extract improved lymphocyte counts and natural killer cell activity over 4 weeks in healthy adults, though effect sizes were modest. A 2010 double-blind RCT (n=93) reported reduced subjective fatigue and improved cognitive performance under stress with 300 mg/day of ethanolic extract, but larger replication trials are lacking. The overall evidence base is preliminary; most mechanistic data derives from animal models and in vitro studies, and definitive efficacy claims await adequately powered, long-term human trials.

Nutritional Profile

Eleutherococcus senticosus (Siberian Ginseng) root and rhizome contain a complex array of bioactive compounds rather than significant conventional macronutrients or micronutrients in typical supplemental doses. Primary bioactive constituents include: Eleutherosides (0.6–0.9% in standardized extracts) — a heterogeneous group comprising eleutheroside B (syringin, a phenylpropanoid glucoside, ~0.1–0.5 mg/g dry root), eleutheroside E (syringaresinol diglucoside, a lignan, ~0.6–0.9 mg/g dry root), and eleutherosides A, C, D, F, and G at lower concentrations. Polysaccharides (eleutherans A–G) constitute approximately 3–7% of dry root weight and are the primary immune-modulatory fraction. Isofraxidin (a coumarin) is present at approximately 0.05–0.2 mg/g dry root and is associated with anti-inflammatory COX/NF-κB pathway modulation. Ciwujianosides (saponin glycosides) are present in leaf fractions at approximately 0.1–0.3% and contribute to mast cell stabilization. Chlorogenic acid and caffeic acid derivatives are present at trace levels (~0.02–0.05 mg/g). Protein content is negligible in standardized extracts (~1–3% in raw root powder). Carbohydrate content in raw root is approximately 60–70% dry weight, primarily as structural polysaccharides and starches with limited nutritional bioavailability. Mineral content in raw root includes modest potassium (~8–12 mg/g dry weight), calcium (~2–4 mg/g), and magnesium (~1–2 mg/g), though these are largely irrelevant at supplemental doses (typical 300–1200 mg/day). Bioavailability note: Eleutheroside B and E are absorbed via intestinal passive diffusion with moderate bioavailability; polysaccharides exert primarily luminal and gut-associated lymphoid tissue (GALT) effects with limited systemic absorption. Standardization is typically to ≥0.8% eleutherosides (calculated as eleutheroside E) per USP/WHO guidelines.

Preparation & Dosage

Standardized capsule (≥1% eleutheroside E): 200-400 mg daily in 2 divided doses. Whole powder: 2-4 g daily in two divided doses. Tincture (1:2, 25%): 2-8 ml once daily. Optimal timing involves morning and noon dosing with a recommended schedule of 6 weeks on, 2 weeks off. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rhodiola rosea, Ashwagandha, American ginseng, Schisandra berry, Cordyceps

Safety & Interactions

Eleutherococcus senticosus is generally well-tolerated at doses of 300–800 mg/day of standardized extract for up to 6 months, with mild reported side effects including insomnia, irritability, and transient hypertension at higher doses. It may potentiate the effects of anticoagulants such as warfarin by inhibiting CYP2C9-mediated metabolism, and has been reported to elevate serum digoxin levels, complicating therapeutic drug monitoring. The herb is contraindicated in individuals with uncontrolled hypertension and should be used cautiously in those on immunosuppressive therapy given its immune-stimulatory polysaccharide activity. Pregnancy and breastfeeding safety has not been established in controlled human studies, and avoidance is generally recommended during these periods.